← FDA Drug Approvals (Drugs@FDA)

DESVENLAFAXINE SUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL · Approved 2016-07-29

Drug application

FDA Application #

ANDA204065

Application type

Abbreviated New Drug Application (Generic)

Brand name

DESVENLAFAXINE SUCCINATE

Generic name

DESVENLAFAXINE

Active ingredients

DESVENLAFAXINE SUCCINATE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

ACTAVIS LABS FL

Manufacturer

Actavis Pharma, Inc.

First approval

2016-07-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown